Up-to-date overview of clinical trials in Duchenne muscular dystrophy (DMD) — AAV microdystrophin gene therapy, exon-skipping antisense oligonucleotides, gene editing, anti-inflammatory and other investigational therapies recruiting patients in the US and worldwide — automatically compiled from ClinicalTrials.gov. Refer eligible patients to participating research centers.
8 studies found
Sarepta Therapeutics, Inc.
Solid Biosciences Inc.
Sardocor Corp.
Dyne Therapeutics
Precision BioSciences, Inc.
University of Florida
Masonic Cancer Center, University of Minnesota
Anne M. Connolly
Data deletion (LGPD/GDPR), partnerships, referrals, or any other matter.